Cons: Should a patient with stage IA non-small cell lung cancer undergo invasive mediastinal staging?

Herbert Decaluwé, Christophe Dooms


In patients with (suspected) NSCLC and absence of metastases, current treatment guidelines are at large based on the extent of intrathoracic nodal disease. The rationale for preoperative invasive mediastinal nodal staging is to identify with the highest certainty and the lowest morbidity those patients with mediastinal nodal disease, as upfront surgery is not indicated in patients with mediastinal nodal disease (1).